Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit
Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit
Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.